Literature DB >> 7273824

Computed tomography attenuation values in fatty liver.

G M Bydder, R W Chapman, D Harry, L Bassan, S Sherlock, L Kreel.   

Abstract

The accuracy of CT diagnosis of increased fat deposition in the liver was assessed in 11 alcoholic patients with suspected fatty liver. Single-energy CT attenuation values were compared with histological assessment of fatty liver and chemical analysis of liver triglyceride concentrations, obtained from liver biopsy specimens. Measured attenuation values showed an inverse correlation with the degree of fatty change assessed histologically (r =--0.90; p Less Than 0.0001) and with that assessed chemically (r=--0.57; p Less Than 0.05). CT scanning may provide a useful non-invasive method for detecting and following patients with fatty liver, particularly when liver biopsy is contraindicated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273824     DOI: 10.1016/0149-936x(81)90054-0

Source DB:  PubMed          Journal:  J Comput Tomogr        ISSN: 0149-936X


  19 in total

Review 1.  Nonalcoholic fatty liver disease: a clinical review.

Authors:  David A Sass; Parke Chang; Kapil B Chopra
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort.

Authors:  Xianghai Zhou; Yufeng Li; Xiuying Zhang; Ying Ying Guan; Yindra Puentes; Fang Zhang; Elizabeth K Speliotes; Linong Ji
Journal:  Diabetes Metab Res Rev       Date:  2019-04-17       Impact factor: 4.876

3.  Comparison of new and conventional versions of model-based iterative reconstruction in reduced-dose computed tomography for diagnosis of hepatic steatosis.

Authors:  Koichiro Yasaka; Masaki Katsura; Jiro Sato; Masaaki Akahane; Izuru Matsuda; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2016-02-23       Impact factor: 2.374

4.  A Model to Predict Significant Macrosteatosis in Hepatic Grafts.

Authors:  Ahmed Swelam; René Adam; Lelde Lauka; Luiza Basilio Rodrigues; Sherif Elgarf; Mylène Sebagh; Nicolas Golse; Antonio Sa Cunha; Daniel Cherqui; Denis Castaing; Marc-Antoine Allard
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

5.  Focal fatty liver lesions in alcoholic liver disease: a broadened spectrum of CT appearances.

Authors:  P Tang-Barton; W Vas; J Weissman; Z Salimi; R Patel; L Morris
Journal:  Gastrointest Radiol       Date:  1985

Review 6.  Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD.

Authors:  Peter M Graffy; Perry J Pickhardt
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

7.  Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis.

Authors:  Irfan Zeb; Dong Li; Khurram Nasir; Ronit Katz; Vahid N Larijani; Matthew J Budoff
Journal:  Acad Radiol       Date:  2012-04-21       Impact factor: 3.173

8.  Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis.

Authors:  Jingzhong Ding; Stephen B Kritchevsky; Fang-Chi Hsu; Tamara B Harris; Gregory L Burke; Robert C Detrano; Moyses Szklo; Michael H Criqui; Matthew Allison; Pamela Ouyang; Elizabeth R Brown; J Jeffrey Carr
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

9.  Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA).

Authors:  Luis A Rodriguez; Alka M Kanaya; Stephen C Shiboski; Alicia Fernandez; David Herrington; Jingzhong Ding; Patrick T Bradshaw
Journal:  Ann Epidemiol       Date:  2021-07-19       Impact factor: 3.797

10.  Relationships between fat deposition in the liver and skeletal muscle and insulin sensitivity in Japanese individuals: a pilot study.

Authors:  Eiichi Yoshimura; Hideaki Kumahara; Takuro Tobina; Sakiko Matono; Akira Kiyonaga; Miyuki Kimura; Hiroshi Tsukikawa; Shinya Kono; Takashi Etou; Shin Irie; Keizo Anzai; Hiroaki Tanaka
Journal:  Diabetes Metab Syndr Obes       Date:  2011-01-20       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.